Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$76.96
+0.9%
$72.30
$67.37
$130.14
$13.31B1.251.38 million shs904,443 shs
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$11.91
$11.91
$11.11
$13.72
$9.77M0.961,591 shsN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
$103.69
-0.2%
$103.19
$100.46
$107.84
$145.47M0.138,427 shs1,887 shs
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
$1.86
+2.2%
$1.50
$0.19
$2.65
$32.74M3.081.39 million shs12,482 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
0.00%+5.00%+8.86%-5.37%-34.29%
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00%0.00%0.00%0.00%0.00%
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
0.00%-0.36%+0.44%-0.93%+1.05%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
+2.20%+5.68%+28.08%+58.30%-43.81%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
4.6383 of 5 stars
3.13.04.22.22.81.71.3
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
2.17
Hold$99.5429.35% Upside
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00
N/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
0.00
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest HILS, ARE, BAD, SSM, and GBF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/12/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$129.00 ➝ $102.00
6/12/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$121.00 ➝ $91.00
6/2/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$110.00 ➝ $74.00
5/20/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$117.00 ➝ $95.00
5/12/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$114.00 ➝ $100.00
4/30/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$103.00 ➝ $91.00
4/30/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral$104.00 ➝ $76.00
4/30/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$130.00 ➝ $130.00
4/29/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
BNP Paribas Exane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral$111.00 ➝ $85.00
4/16/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price Target$116.00 ➝ $103.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$3.12B4.27$8.43 per share9.13$129.29 per share0.60
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
N/AN/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/A$0.48 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$322.95M$0.76101.268.006.484.62%0.64%0.38%7/21/2025 (Estimated)
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/A16.67N/AN/AN/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
-$8.47M-$0.72N/AN/AN/AN/A-188.44%-149.61%N/A

Latest HILS, ARE, BAD, SSM, and GBF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/21/2025Q2 2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.30N/AN/AN/A$748.02 millionN/A
4/28/2025Q1 2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.28$2.30+$0.02$1.65$755.64 million$758.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$5.286.86%N/A694.74%15 Years
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$0.080.67%N/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
$3.993.85%N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/A

Latest HILS, ARE, BAD, SSM, and GBF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/2/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
quarterly$1.327.64%6/30/20256/30/20257/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
0.60
0.22
0.22
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/A
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
N/AN/AN/A
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/A
3.01
3.01
CompanyEmployeesShares OutstandingFree FloatOptionable
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
590172.99 million171.12 millionOptionable
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/A820,000N/ANot Optionable
iShares Government/Credit Bond ETF stock logo
GBF
iShares Government/Credit Bond ETF
N/A1.40 millionN/ANot Optionable
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
117.60 million12.28 millionNot Optionable

Recent News About These Companies

Police identify 41-year-old killed in Winton Hills shooting
Hill & Smith PLC HILS
Kiromic BioPharma Inc Ordinary Shares KRBP
NMTRQ 9 Meters Biopharma, Inc.
HILS - Hillstream BioPharma, Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alexandria Real Estate Equities stock logo

Alexandria Real Estate Equities NYSE:ARE

$76.96 +0.69 (+0.90%)
Closing price 07/3/2025 03:45 PM Eastern
Extended Trading
$76.96 0.00 (0.00%)
As of 07/3/2025 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

B.A.D. Etf stock logo

B.A.D. Etf NYSEARCA:BAD

$11.91 0.00 (0.00%)
As of 11/29/2023

The B.A.D. ETF (BAD) is an exchange-traded fund that is based on the EQM BAD index. The fund tracks a modified equal-weighted index of US-listed companies engaged in betting, alcohol, cannabis, and drugs. BAD was launched on Dec 22, 2021 and is managed by The BAD Investment Company.

iShares Government/Credit Bond ETF stock logo

iShares Government/Credit Bond ETF NYSEARCA:GBF

$103.69 -0.23 (-0.22%)
As of 07/3/2025 05:00 PM Eastern

iShares Government/Credit Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of the United States dollar-denominated government, government-related and investment-grade the United States corporate bonds. The Fund seeks to track the investment results of the Barclays U.S. Government/Credit Bond Index (the Underlying Index), which measures the performance of the United States dollar-denominated United States Treasury bonds, government-related bonds (i.e., the United States and foreign agencies, sovereign, supranational and local authority debt) and investment-grade United States corporate bonds, which have a remaining maturity of greater than or equal to one year. The Underlying Index may include large-, mid- or small-capitalization companies, and components include agency and treasury securities, and financial and industrials companies. BlackRock Fund Advisors serves as investment adviser of the Fund.

Hillstream BioPharma stock logo

Hillstream BioPharma NASDAQ:HILS

$1.86 +0.04 (+2.20%)
As of 07/3/2025

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.